Generate Biomedicines, Inc. · NASDAQ:GENB

Generate Biomedicines, Inc. financial statements

Generate Biomedicines, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024
Revenue31.9M20.5M
Gross profit31.9M20.5M
Research and development224.7M175.3M
Selling, general and administrative42.3M42.1M
Operating income-235.1M-196.9M
Depreciation and amortization13.2M15.3M
EBITDA-221.9M-181.6M
Interest expense1.14M2.12M
Income before tax-222.8M-181.2M
Income tax163.0K212.0K
Net income-203.2M-173.8M
Earnings per share, basic-4.06-1.36

Balance sheet

LineFY2025FY2024
Cash and equivalents121.7M176.3M
Short-term investments99.8M217.4M
Receivables0308.0K
Current assets234.4M407.5M
Total assets330.2M518.3M
Accounts payable3.84M5.67M
Current liabilities82.2M86.6M
Total debt68.5M77.0M
Total liabilities953.4M953.3M
Shareholders' equity-616.0M-434.5M
Shares outstanding50.1M127.5M

Cash flow

LineFY2025FY2024
Cash from operations-200.6M-117.8M
Capital spending-3.51M-3.45M
Free cash flow-204.1M-121.2M
Cash from investing116.8M-57.7M
Cash from financing28.1M91.3M
Change in cash-55.8M-84.1M